Regeneron Can't Escape Feds' Medicare Kickback Case
Regeneron Pharmaceuticals Inc. must face claims that the millions of dollars it funneled to a patient-support charity were kickbacks meant to convince doctors to prescribe its pricey eye disease drug, a Massachusetts...To view the full article, register now.
Already a subscriber? Click here to view full article